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INTRODUCTION
Immunoglobulin G4 (IgG4)-related kidney disease 
(IgG4-KD) is a comprehensive term indicating the renal 
involvement of IgG4-related sclerosing disease (IgG4-SD), 
which is an immune-mediated systemic disease that can 
affect almost every organ system (1). The most common 
feature of IgG4-KD is tubulointerstitial nephritis with 
increased IgG4-positive plasma cells, along with fibrosis 
(1-6). IgG4-KD usually responds well to steroid therapy; 
however, if not properly treated, it may cause acute or 
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chronic renal dysfunction and can progress to irreversible 
renal failure (6). Therefore, a timely and accurate diagnosis 
that ensures early steroid treatment is crucial for improving 
the patient outcome. In addition, as IgG4-KD is usually 
associated with IgG4-SD involving other organs, including 
autoimmune pancreatitis (AIP) or IgG4-related sclerosing 
cholangitis, identifying the renal lesions can provide clues 
for diagnosing IgG4-SD (5-9). Therefore, radiologists must 
be aware of the imaging features of IgG4-KD, as well as 
also be familiar with this disease entity. The purpose of this 
article is to provide a comprehensive pictorial review of the 
imaging spectrum of IgG4-KD, and to discuss differential 
diagnosis from its mimickers. We will also briefly review the 
clinicopathologic characteristics of IgG4-KD.
Clinicopathologic Characteristics of IgG4-KD
Immunoglobulin G4-related kidney disease usually affects 
middle-aged or elderly patients and shows a definite male 
predominance (73–90%), which is similar in patients with 
IgG4-SD involving other organs (5, 7, 9, 10). IgG4-KD is 
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Fig. 1. 72-year-old man who underwent left nephrectomy due to IgG4-KD mimicking urothelial carcinoma.
A. Contrast-enhanced CT image shows ill-defined, homogeneous, soft-tissue mass (arrow) which encases left renal pelvis causing hydronephrosis. 
B. He underwent left nephrectomy with diagnosis of having urothelial carcinoma. Photograph of surgical specimen demonstrates lobulated, 
yellowish, firm mass (arrows) around renal pelvis. C, D. Lower-power (x 100) (C) and higher-power (x 400) (D) photomicrographs of histological 
specimen (hematoxylin and eosin staining) show dense plasma cell infiltration (arrows) with fibrous background (Fi) and obliterative phlebitis 
(arrowheads). E. IgG4 immunostaining (x 100) of histologic specimen shows numerous, brown, IgG4-positive plasma cells. IgG4-KD = 
immunoglobulin G4-related kidney disease
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usually accompanied by other organ involvement in IgG4-
SD, typically AIP, and approximately 1/4 or 1/3 of AIP 
patients have IgG4-KD (11-13). Isolated cases of IgG4-KD 
without other organ involvement, is very rare. In our series, 
only 3 (6%) of 48 IgG4-KD patients had renal lesions alone.
The clinical manifestations are usually mild or even 
asymptomatic. As the disease progresses, renal dysfunction 
or abnormalities are seen in imaging studies; only then it 
becomes clinically evident. Renal function at the time of the 
initial diagnosis varies from normal function to renal failure. 
Mild proteinuria occurs in approximately half the patients 
(7, 10). Hypergammaglobulinemia, either IgG4 or total IgG, 
is the serologic hallmark of IgG4-KD as well as IgG4-SD. 
Although up to 30% of patients with IgG4-SD have a normal 
range of serum IgG4 level, almost all IgG4-KD patients 
have an elevated serum IgG4 level (7, 10). Other serologic 
findings include an elevated serum immunoglobulin E level, 
eosinophilia, and hypocomplementemia (1, 5).
Immunoglobulin G4-related kidney disease manifests 
most commonly as tubulointerstitial nephritis, followed by 
glomerular disease such as membranous glomerulonephritis 
(1). Other less frequent conditions, including IgG4-
related chronic sclerosing pyelitis, IgG4-related plasma-
cell arteritis, and IgG4-related inflammatory pseudotumors 
of the ureter, have also been reported (1, 14-16). The key 
histologic findings of IgG4-KD are dense lymphoplasmacytic 
infiltration with increased IgG4-positive plasma cells, 
and storiform fibrosis, both of which are identical to the 
findings of IgG4-SD involving other organs (Fig. 1) (3, 10). 
In addition, the characteristic microscopic features of IgG4-
A B
Fig. 2. 49-year-old man with IgG4-KD manifesting as multiple, renal parenchymal nodules.
A, B. Contrast-enhanced arterial (A) and portal (B) phase CT images show multiple, small, round or wedge-shaped, hypodense nodules (arrows) 
in both kidneys, predominantly in cortex. Renal nodules progressively enhance in portal phase. IgG4-KD = immunoglobulin G4-related kidney 
disease
A B
Fig. 3. IgG4-KD manifesting as diffuse patchy infiltrative parenchymal lesions.
A. 66-year-old man. Contrast-enhanced portal phase CT image shows patchy infiltrative hypodense lesions (arrows) in both kidneys. B. 56-year-
old man. T2-weighted MR image shows diffuse patchy infiltrative lesions appearing noticeably hypointense (arrows) in both kidneys. IgG4-KD = 
immunoglobulin G4-related kidney disease
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related tubulointerstitial nephritis are nests of inflammatory 
cells with irregular fibers surrounding them, and immune 
complex deposition in the tubular basement membrane (5, 
17, 18).
Imaging Spectrum of IgG4-KD
The diagnosis of IgG4-KD is based on a combination 
of imaging, serologic and histologic findings, as well as 
other organ involvement (5, 7). Among these findings, the 
imaging findings may be the most important component 
as they are usually the first recognized abnormal findings 
of IgG4-KD, which enables clinicians or radiologists to 
consider the occurrence of this disease. Therefore, it is 
crucial to be aware of the imaging spectrum of IgG4-KD in 
order to obtain a timely and accurate diagnosis.
Distribution of IgG4-KD
Immunoglobulin G4-related kidney disease can be 
divided into three types, based on their location: renal 
parenchymal, renal pelvic, and a perinephric lesion. A renal 
parenchymal lesion is the most common type, followed by a 
renal pelvic and a perinephric lesion (9, 12, 19). Two types 
can sometimes appear together. Among the 48 IgG4-KD 
patients seen at our institution, 36 (75%) had only renal 
parenchymal lesions, 5 (10%) had only renal pelvic lesions, 
and 1 (2%) had only perinephric lesions. Two types of IgG4-
KD co-existed in 6 (13%) patients: 5 with renal parenchymal 
A
C
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Fig. 4. MR imaging features of IgG4-KD in 64-year-old man.
A. On precontrast T1-weighted image, isointense renal lesions are not perceptible. B. T2-weighted image shows three, small, hypointense cortical 
nodules (arrows) in both kidneys. C, D. DWI (b value, 1000 s/mm2) (C) and ADC map (D) reveal renal nodules (arrows) which appear as having 
obvious hyperintensity and hypointensity, respectively, and representing diffusion restriction. ADC = apparent diffusion coefficient, DWI = 
diffusion-weighted MR imaging, IgG4-KD = immunoglobulin G4-related kidney disease
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and renal pelvic lesions, and 1 with renal parenchymal 
and perinephric lesions. Because of the systemic nature 
of the disease, IgG4-KD typically shows multiplicity and 
bilaterality (9, 19, 20). In our series, 45 (94%) and 37 (77%) 
patients had multiple and bilateral lesions, respectively.
Renal Parenchymal Lesions
A renal parenchymal lesion in IgG4-KD can show three 
patterns: a single nodule, multiple nodules (Fig. 2), and 
diffuse patchy infiltrative lesions (Fig. 3). Among these, 
multiple nodules are the most common pattern (12, 19, 
20). Renal parenchymal nodules are located predominantly 
in the renal cortex. They are usually small and round, or 
wedge-shaped. It rarely appears as a single, large, mass-like 
lesion mimicking a solid renal neoplasm (9, 12, 19).
On contrast-enhanced CT, renal parenchymal lesions are 
mostly hypodense to the normal renal cortex in the early 
phase, i.e., the arterial or corticomedullary phase, and 
progressively get enhanced in the portal or delayed phase 
(Fig. 2) (19-21). These lesions are usually not visible on 
precontrast CT scans (12, 19). It can often be challenging 
to perceive early, subtle renal lesions depending solely on 
CT scans. MR imaging can improve detection of the lesions 
in such cases. On T2-weighted MR images, renal lesions 
typically appear hypointense relative to the normal renal 
parenchyma, and are easily detectable due to the obvious 
contrast between the dark lesions and the bright, normal 
parenchyma (Figs. 3, 4) (9, 12, 22). On the other hand, 
A
C
B
D
Fig. 5. MR imaging features of IgG4-KD in 72-year-old man.
A-C. Dynamic contrast-enhanced MR images show small cortical nodule (arrows) in right kidney, and which appears hypointense in arterial phase 
(A) and progressively enhanced in portal (B) and delayed (C) phases, gradually becoming indistinct as phase passes. D. On DWI (b value, 1000 
s/mm2), right renal lesion exhibits striking hyperintensity (arrow). DWI = diffusion-weighted MR imaging, IgG4-KD = immunoglobulin G4-related 
kidney disease
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renal lesions usually appear isointense on T1-weighted 
images, and they are barely visible or are invisible (Fig. 
4). On dynamic contrast-enhanced MR images, most renal 
lesions are hypointense to the normal renal cortex in the 
arterial phase, and progressively enhance in the portal and 
delayed phases, thus becoming indistinct as the phase 
passes; this is similar to the dynamic enhancement pattern 
seen on CT (Fig. 5) (9, 12, 22). Diffusion-weighted MR 
imaging (DWI) has recently been reported to be particularly 
useful for detecting IgG4-KD (9). Kim et al. (9) reported 
that the sensitivity of DWI (b value, 1000 s/mm2) for 
detecting IgG4-KD was significantly higher than that of 
T2-weighted images (100% vs. 77%). The renal lesions 
have marked hyperintensity on DWI at a high b value and, 
conversely, have marked hypointensity on the apparent 
diffusion coefficient map (Figs. 4, 5). These DWI findings 
can be explained by the histopathologic background of 
IgG4-KD, i.e., dense lymphoplasmacytic infiltration with 
fibrosis. This may be supported by the hypointensity seen 
on T2-weighted images and the progressive enhancement 
pattern seen on dynamic contrast-enhanced images, which 
may also represent fibrosis (9, 12). DWI may also have the 
potential to detect IgG4-KD at an early or subclinical stage 
(9, 23).
Ultrasonographic (US) findings of IgG4-KD are not 
specific and are less sensitive for lesion detection than CT 
or MR imaging (24). The most common US findings are ill-
defined, non-mass-like areas of decreased echogenicity (24). 
Other US findings include irregular lobular thickening of 
the renal parenchyma with a bulging contour and multiple, 
hypoechoic masses with decreased vascularity, as compared 
to the normal renal cortex (24).
Renal Pelvic and Perinephric Lesions
Renal pelvic or perinephric lesions are much rarer than 
renal parenchymal lesions. Renal pelvic lesions manifest as 
diffused wall thickening of the renal pelvis, or as a mildly 
enhanced, soft-tissue mass encasing the renal pelvis (12, 
19). These lesions can be unilateral (Fig. 6) or bilateral 
(Fig. 7). Hydronephrosis seldom occurs, unless the ureter 
is entrapped by accompanying periaortic retroperitoneal 
fibrosis. In our series, only 1 of 10 patients with renal 
pelvic lesions had a mild, unilateral hydronephrosis without 
retroperitoneal fibrosis. Perinephric lesions typically 
Fig. 6. 64-year-old man with IgG4-KD manifesting as unilateral 
renal pelvic lesion. Contrast-enhanced arterial phase CT image shows 
ill-defined, mildly enhancing, soft-tissue mass (arrow) encasing right 
renal pelvis and without hydronephrosis. IgG4-KD = immunoglobulin 
G4-related kidney disease
Fig. 7. 84-year-old man with IgG4-KD manifesting as bilateral renal pelvic lesions. Contrast-enhanced portal phase CT images show 
mildly enhanced wall thickening of both renal pelvises (arrows) and without hydronephrosis. Pancreatic head enlargement with heterogeneous 
attenuation (arrowheads), indicating autoimmune pancreatitis, is also seen. IgG4-KD = immunoglobulin G4-related kidney disease
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appear as a diffuse, rim-like, soft-tissue mass surrounding 
the kidneys (Fig. 8) (12). These masses usually exhibit 
homogeneous and mild enhancement. They can be also 
unilateral or bilateral.
Response of IgG4-KD to Steroid Therapy
Immunoglobulin G4-related kidney disease usually shows 
a rapid and favorable response to steroid therapy, which 
similar to IgG4-SD with other organ involvement, regardless 
of the lesion location (i.e., renal parenchymal, renal pelvic 
or perinephric). According to the pathologic subtype, 
tubulointerstitial nephritis generally responds better than 
membranous glomerulonephritis (1). Approximately 90% 
of IgG4-KD patients show improvement of decreased renal 
function and abnormal imaging findings with steroid 
treatment (1, 10, 12, 17, 19). During the steroid treatment, 
the lesion size and number dramatically decreases, as 
seen on imaging studies (Fig. 9). After completion of 
the steroid therapy, varying degrees of renal atrophy can 
develop, especially in patients with renal parenchymal 
lesions, and which may be proportionate to the extent of 
the renal involvement before treatment (6, 10, 12). In our 
series, the majority of patients having renal parenchymal 
Fig. 8. 74-year-old man with IgG4-KD manifesting as 
perinephric lesion. Contrast-enhanced arterial phase CT image shows 
homogeneous, rim-like, soft-tissue mass surrounding both kidneys 
(arrows). Peri-aortic, soft-tissue lesion, indicating retroperitoneal 
fibrosis, is also observed (arrowhead). IgG4-KD = immunoglobulin G4-
related kidney disease
A
C
B
Fig. 9. Response of IgG4-KD to steroid therapy in 72-year-old man.
A. Contrast-enhanced CT image shows diffuse infiltrative lesion (arrows) in right kidney. B. Contrast-enhanced CT image obtained after 
completion of steroid treatment demonstrates improvement of right renal lesion. However, multifocal, tiny cortical scars remain (arrows). C. 
Contrast-enhanced CT image obtained two years after steroid cessation reveals nodular or infiltrative lesions in right kidney (arrows), thus 
indicative of disease relapse. IgG4-KD = immunoglobulin G4-related kidney disease
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lesions of a diffuse patchy infiltrative pattern, or with 
large, multiple nodules, experienced mild cortical scars 
after steroid therapy (Fig. 9). IgG4-KD as well as other 
organ involvement of IgG4-SD can relapse in up to 20% 
of patients, mainly during maintenance therapy or after 
cessation of the steroid therapy (Fig. 9) (6, 12). Without 
steroid treatment, the renal lesions can increase in size and 
number, or progress to diffuse cortical involvement (12).
Mimickers of IgG4-KD and the Differential 
Diagnosis
As stated above, IgG4-KD has a broad spectrum of 
imaging features. Therefore, various neoplastic or non-
neoplastic conditions of the kidneys can mimic IgG4-
KD. With regard to IgG4-KD manifesting as multiple, renal 
parenchymal lesions, the differential diagnosis includes 
acute pyelonephritis, infarction, metastasis, and lymphoma 
(Fig. 10) (9, 12, 20). Acute pyelonephritis typically appear 
as unilateral or bilateral, multiple, ill-defined, and round 
or wedge-shaped lesions of decreased enhancement (Fig. 
10A) (25, 26). Clinical findings, which include fever, pyuria 
or knocking tenderness in the flank area, may undoubtedly 
be important clues suggesting acute pyelonephritis. 
In addition to the aforementioned clinical findings, 
perilesional infiltration or fluid collection, and renal or 
A
C
B
D
Fig. 10. Mimickers of IgG4-KD manifesting as multiple, renal parenchymal lesions.
A. 32-year-old woman with acute pyelonephritis. Contrast-enhanced delayed phase CT image shows multifocal, ill-defined, round and wedge-
shaped, hypodense lesions (arrows) with mild swelling in left kidney. B. 53-year-old man with renal infarction. Contrast-enhanced arterial phase 
CT image shows large, rather well-demarcated, wedge-shaped areas of poor contrast enhancement (arrows) in both kidneys. C. 75-year-old man 
with renal metastases from lung cancer. Contrast-enhanced arterial phase CT image shows round, hypodense nodules (arrows) in both kidneys. 
D. 61-year-old man with renal lymphomas. Contrast-enhanced portal phase coronal CT image shows several, well-defined, homogeneous, round 
nodules/masses (arrows) in both kidneys. IgG4-KD = immunoglobulin G4-related kidney disease
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perirenal abscesses seen on imaging examinations, may 
also help to differentiate acute pyelonephritis from IgG4-
KD. Well-demarcated, large, wedge-shaped areas showing 
poor contrast enhancement are typical of renal infarction, 
although they may mimic the patchy infiltrative pattern 
of IgG4-KD (Fig. 10B) (25, 27). A hyperenhanced cortical 
rim at the lesion periphery, the so-called cortical rim sign, 
can be seen in approximately half of the patients with 
renal infarction, whereas in IgG4-KD this sign has never 
been reported in the published medical literature, including 
our study (27, 28). Metastases usually appear as bilateral, 
multiple, and less exophytic nodules, and they are therefore 
capable of closely mimicking IgG4-KD (Fig. 10C) (29). The 
presence of primary malignancy is the most important clue 
A B
Fig. 11. Mimicker of IgG4-KD manifesting as single parenchymal nodule.
A, B. 78-year-old man with chromophobe-type renal cell carcinoma. Contrast-enhanced arterial (A) and delayed (B) phase CT images 
demonstrate single hypovascular nodule (arrows) in right kidney. IgG4-KD = immunoglobulin G4-related kidney disease
to metastasis. The common sites of primary malignancy 
are the lung, breast, contralateral kidney, and colon 
(30). Renal lymphomas commonly manifest as multiple, 
parenchymal nodules/masses (Fig. 10D), or as a renal pelvic 
or perinephric mass with mild homogeneous enhancement, 
which can be quite similar to the IgG4-KD features (31-
33). Moreover, lymphomas often appear hypointense on 
T2-weighted MR images and have diffusion restriction (33, 
34). However, renal lymphomas seem more bulky than IgG4-
KD and frequently accompany multiple, retroperitoneal 
lymphadenopathies, compared to IgG4-KD (9, 32).
In rare cases, when IgG4-KD manifests as a single 
parenchymal nodule/mass, it can be challenging to 
distinguish it from renal cell carcinoma, especially when 
non-clear cell types, such as the papillary or chromophobe 
type, appear as a non-hypervascular mass (Fig. 11) (35). 
Diffuse wall thickening of the renal pelvis or a parapelvic 
mass in IgG4-KD should be differentiated from urothelial 
carcinoma (Fig. 12). The relatively common bilaterality and 
uncommon hydronephrosis in IgG4-KD may be helpful in 
differentiating the two diseases, and may warrant further 
comparative studies.
In addition to the above-mentioned analyses regarding 
the imaging features, detection of other organ involvement 
of IgG4-SD, i.e., AIP (Fig. 13), sclerosing cholangitis, 
retroperitoneal fibrosis (Fig. 13) or sialadenitis, may 
be essential for differentiating IgG4-KD from the other 
diseases, as isolated IgG4-KD without other organ 
involvement is very rare, as demonstrated in our study 
(6%). According to recently established diagnostic criteria 
of IgG4-KD, the presence of other organ involvement is 
an important diagnostic component (5, 7). Alternatively, 
Fig. 12. Mimicker of IgG4-KD manifesting as renal pelvic 
lesion. 63-year-old man with transitional cell carcinoma. Contrast-
enhanced portal phase CT image shows diffusely enhancing wall 
thickening of right renal pelvis (arrow) and surrounding soft-tissue 
lesion (arrowhead). IgG4-KD = immunoglobulin G4-related kidney 
disease
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A B
Fig. 13. Retroperitoneal fibrosis and autoimmune pancreatitis as clues to diagnosis of IgG4-KD in 71-year-old man.
A, B. Contrast-enhanced portal phase CT images show several, well-defined, round, hypodense nodules (arrows) in both kidneys. Differential 
diagnosis for these renal lesions would be lymphoma, metastasis or IgG4-KD. However, periaortic, soft-tissue lesion (arrowhead in A) suggesting 
retroperitoneal fibrosis and sausage-shaped pancreas swelling with peripancreatic hypodense rim (arrowheads in B) which is typical of AIP, 
are observed together. Accordingly, such renal lesions can confidently be diagnosed as IgG4-KD. AIP = autoimmune pancreatitis, IgG4-KD = 
immunoglobulin G4-related kidney disease
A
C
B
D
Fig. 14. IgG4-KD as clue for differentiating autoimmune pancreatitis from pancreatic cancer in 64-year-old man.
A, B. Precontrast T1-weighted MR image (A) shows hypointense, mass-like enlargement of pancreatic head (arrow). MR cholangiopancreatography 
(B) shows abrupt, severe narrowing of pancreatic and bile ducts (arrowheads) with upstream duct dilatation. These MR findings are highly 
suggestive of pancreatic cancer. C, D. DWIs (b value, 1000 s/mm2) show multifocal, hyperintense nodules (arrows) in right kidney. Combination of 
these renal lesions and pancreatic mass/enlargement strongly suggests IgG4-SD, i.e., IgG4-KD and focal type AIP. AIP = autoimmune pancreatitis, 
DWI = diffusion-weighted MR imaging, IgG4-KD = immunoglobulin G4-related kidney disease, IgG4-SD = IgG4-related sclerosing disease
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identification of renal lesions can be of crucial importance 
for the diagnosis of IgG4-SD involving other organs, 
especially when imaging features of other organs are not 
characteristic of IgG4-SD. A typical example would be the 
differential diagnosis of focal-type AIP and pancreatic 
cancer; in this situation, the presence of renal lesions may 
substantially favor the former diagnosis (Fig. 14) (8).
On the other hand, despite the detailed analysis using 
various imaging modalities, it can still be difficult to 
differentiate IgG4-KD from other diseases, in particular 
neoplasms. In such cases, CT- or US-guided biopsy of 
the renal lesions should be considered, in order to avoid 
unnecessary surgery caused by the misdiagnosis as 
neoplasm, in patients having IgG4-KD.
CONCLUSION
Immunoglobulin G4-related kidney disease has a broad 
spectrum of imaging features and a variety of mimickers to 
be differentiated from it. Awareness of the broad imaging 
spectrum of IgG4-KD, differential diagnosis from its 
mimickers, and important clinicopathologic characteristics, 
will facilitate its accurate and prompt diagnosis as well as 
optimally timed treatment.
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